Ohg. Wilder-smith et al., Midazolam premedication and thiopental induction of anaesthesia: interactions at multiple end-points, BR J ANAEST, 83(4), 1999, pp. 590-595
Citations number
24
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
We have studied the effects of midazolam premedication on multiple anaesthe
tic end-points (hypnotic, loss of verbal contact (LVC); motor, dropping an
infusion flex or bag (DF); analgesic, loss of reaction to painful stimulati
on (LRP); and EEG, attainment of burst suppression (BUR)) during induction
by slow thiopental infusion at a rate of 55 mg kg(-1) h(-1). Patients recei
ved midazolam 0.05 mg kg(-1) i.v. (group TM, n = 12) or no midazolam (group
TO, n = 13). ED50 and ED95 values and group medians for times and doses at
the end-points were measured. Midazolam premedication reduced significantl
y thiopental ED50 and ED95 values at all endpoints (exception for ED95 for
BUR). Potentiation was greatest for the motor end-point (dropping the infus
ion bag (DF)) (ED95 + 52%, ED50 +23%, median +39%), and smallest for painfu
l stimulation (LRP) (median +18%; ED50 +13%) For LRP and DF, premedication
was associated with significant, non-parallel increases in the slope of the
thiopental dose-response curves, resulting in marked potency ratio changes
from ED50 to ED95 (LRP +31%, DF +29%). There were no such increases for LV
C or BUR. The interaction between midazolam and thiopental varied with the
anaesthetic end-point and may also depend on the dose of thiopental. Our da
ta suggest that the mechanism of interaction between midazolam premedicatio
n and thiopental was different for motor effects or analgesia (DF, LRP) com
pared with hypnotic effects or cortical depression (LVC, BUR), in agreement
with the different central nervous system substrates underlying these dist
inct anaesthetic end-points.